Home
>
National Drug Code (NDC)
>
RiaSTAP
RiaSTAP - 63833-891-51 - (Fibrinogen)
Drug Information of RiaSTAP
| Product NDC: | 63833-891 |
| Proprietary Name: | RiaSTAP |
| Non Proprietary Name: | Fibrinogen |
| Active Ingredient(s): | 1300 mg/50mL & nbsp; Fibrinogen |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of RiaSTAP
| Product NDC: | 63833-891 |
| Labeler Name: | CSL Behring GmbH |
| Product Type: | PLASMA DERIVATIVE |
| FDA Application Number: | BLA125317 |
| Marketing Category: | BLA |
| Start Marketing Date: | 20090116 |
Package Information of RiaSTAP
| Package NDC: | 63833-891-51 |
| Package Description: | 1 VIAL, SINGLE-USE in 1 CARTON (63833-891-51) > 50 mL in 1 VIAL, SINGLE-USE |
NDC Information of RiaSTAP
| NDC Code | 63833-891-51 |
| Proprietary Name | RiaSTAP |
| Package Description | 1 VIAL, SINGLE-USE in 1 CARTON (63833-891-51) > 50 mL in 1 VIAL, SINGLE-USE |
| Product NDC | 63833-891 |
| Product Type Name | PLASMA DERIVATIVE |
| Non Proprietary Name | Fibrinogen |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20090116 |
| Marketing Category Name | BLA |
| Labeler Name | CSL Behring GmbH |
| Substance Name | FIBRINOGEN |
| Strength Number | 1300 |
| Strength Unit | mg/50mL |
| Pharmaceutical Classes | Human Blood Coagulation Factor [EPC],Increased Coagulation Activity [PE],Blood Coagulation Factors [Chemical/Ingredient] |
